Abstract
Testicular tumors may arise from germinal cells, from cells of the gonadal stroma, or from nongonadal cells. The latter group is referred to as secondary testicular tumors; they usually represent the initial clinical manifestation of a lymphoma or leukemia. The following discussion will be limited to tumors of germinal cell origin, to which group 92% of all testicular tumors belong. These tumors deserve particular attention because the great majority of patients can be cured if adequately treated; because they are associated with true tumor markers that are invaluable in the diagnosis, treatment planning, and follow-up of the disease; and because they are a model for a very successful evolution of therapeutic strategies leading to improvements both of prognosis and quality of life.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hossfeld, D.K. (1982). Cancer of the Testis. In: Sherman, C.D., Hossfeld, D.K., Love, R.R., Bosch, F.X. (eds) Manual of Clinical Oncology. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97267-6_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-97267-6_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52769-5
Online ISBN: 978-3-642-97267-6
eBook Packages: Springer Book Archive